Popees Baby Care India Limited has postponed its Board of Directors meeting originally scheduled for September 22, 2026. The meeting, which was set to deliberate on a proposal to raise funds through a preferential issue of securities, will now take place on October 8, 2026.

The company informed the Bombay Stock Exchange (BSE) that the Board meeting commenced at 9:00 am and concluded at 9:16 am without addressing the agenda items related to the capital raise. The short duration indicates that the primary business was not transacted during this session.

Agenda and Postponement Details

The original agenda included considering and approving the issuance of securities on a preferential basis or through private placement. This capital raise is intended to be executed pursuant to a Share Swap Arrangement for consideration other than cash. The proposal remains subject to applicable statutory and regulatory approvals.

The Board will now consider the following matters at the rescheduled meeting:

• Approval of the proposal for raising funds via securities issuance on a preferential basis/private placement.
• Consideration of terms and conditions associated with the Share Swap Arrangement.
• Other incidental and ancillary matters as decided by the Board with the permission of the Chairperson.

Regulatory Compliance and Next Steps

The intimation was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated it would make necessary disclosures regarding the outcome of the said Board Meeting once held. The Managing Director, Shaju Thomas, signed the communication digitally on September 22, 2026.

Popees Baby Care India Ltd returned to profitability in the financial year ended March 31, 2026, reporting a net profit of ₹9.32 lakh. This marks a reversal from the net loss of ₹9.40 lakh recorded in the previous year. Revenue from operations for the year stood at ₹260.34 lakh, driven primarily by purchases of stock-in-trade amounting to ₹236.67 lakh.

The company's Board of Directors approved the standalone audited financial results at a meeting held on May 30, 2026. C. V. Paturkar & Co., Chartered Accountants, the statutory auditors, issued an audit report with an unmodified opinion. The auditors confirmed that the internal financial controls over financial reporting were adequate and operating effectively as of March 31, 2026.

Total income for FY26 was ₹260.34 lakh, a significant increase from the previous year's nil revenue. Total expenses for the year rose to ₹251.02 lakh from ₹9.40 lakh in FY25. The increase in expenses was largely attributed to purchases of stock-in-trade and other operational costs, including professional charges and audit fees.

The balance sheet as of March 31, 2026, showed total assets of ₹756 lakh, up from ₹382 lakh in the previous year. Equity share capital increased to ₹853 lakh from ₹500 lakh, following an increase in share capital that generated net cash inflows of ₹353 lakh from financing activities. Trade receivables surged to ₹283 lakh from ₹10 lakh, while cash and cash equivalents improved to ₹25 lakh from ₹16 lakh.

Financial Performance Summary

The company reported that it had not granted any loans to companies or firms listed under Section 189 of the Companies Act, 2013, and had not accepted any deposits during the year. No material fraud by the company or its officers was reported during the audit.